Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa psoriasis plaque test of topical AVX001 versus vehicle and active comparators
2019-000175-16Phase 2Completed
- Sponsor
- Avexxin AS
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AVX001 in psoriasis (6 arms), sponsored by Avexxin AS. Primary endpoint: Change in psoriatic infiltrate thickness from baseline to Day 12. Started Feb 2019; status: completed.
02
Drugs
AVX001
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2019-000175-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000175-16.